Bolt Biotherapeutics, Inc. (BOLT)
USD 0.5
(-5.89%)
USD 0.5
(-5.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.87 Million | 5.72 Million | 1.26 Million | 231 Thousand | 215 Thousand | - |
| Cost of Revenue | 61.54 Million | 4.89 Million | 3.67 Million | 40.35 Million | 26 Million | 302 Thousand |
| Gross Profit | -53.66 Million | 838 Thousand | -2.41 Million | -40.12 Million | -25.78 Million | -302 Thousand |
| Operating Expenses | 84.07 Million | 96.05 Million | 94.04 Million | 49.41 Million | 31.18 Million | 11.62 Million |
| Selling, General and Administrative Expenses | 22.53 Million | 22.92 Million | 18.39 Million | 9.05 Million | 5.18 Million | 2.2 Million |
| Research and Development Expenses | 61.54 Million | 73.12 Million | 75.65 Million | 40.35 Million | 26 Million | 9.42 Million |
| Other Expenses | - | - | -6.08 Million | -11.74 Million | -42 Thousand | -153 Thousand |
| Cost and Expenses | 84.07 Million | 96.05 Million | 94.04 Million | 49.41 Million | 31.18 Million | 11.62 Million |
| Operating Income | -76.19 Million | -90.32 Million | -92.78 Million | -49.18 Million | -30.96 Million | -11.62 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -2.22 Million | 5.8 Million | 11.54 Million | -482 Thousand | 40 Thousand |
| Earnings before Tax | -69.19 Million | -88.09 Million | -98.59 Million | -60.72 Million | -30.48 Million | -11.58 Million |
| Net Income | -69.19 Million | -85.87 Million | -104.39 Million | -72.27 Million | -30 Million | -11.58 Million |
| Earnings Per Share Basic | -1.83 | -2.30 | -2.79 | -1.99 | -0.85 | -1.23 |
| Earnings Per Share Diluted | -1.83 | -2.30 | -2.79 | -1.99 | -0.85 | -1.23 |
| Weighted Average Shares Outstanding | 37.81 Million | 37.35 Million | 37.39 Million | 36.24 Million | 35.09 Million | 9.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.81 Million | 37.35 Million | 37.39 Million | 36.24 Million | 35.09 Million | 9.41 Million |
| Gross Margin | -6.81 | 0.15 | -1.91 | -173.71 | -119.94 | - |
| EBIT Margin | -9.44 | -15.47 | -67.87 | -159.42 | -142.29 | - |
| Profit Margin | -8.79 | -14.99 | -82.85 | -312.87 | -139.56 | - |
| EBITDA | -74.34 Million | -88.65 Million | -91.59 Million | -48.57 Million | -30.63 Million | -11.32 Million |
| Earnings Before Tax Margin | -9.67 | -15.77 | -73.64 | -212.91 | -144.04 | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 1.27 Million | 5.27 Million | 7.87 Million | 2.08 Million | 2.52 Million | 1.43 Million |
| Cost of Revenue | 457 Thousand | 458 Thousand | 1.88 Million | 497 Thousand | 462 Thousand | 1.18 Million |
| Gross Profit | 818 Thousand | 4.81 Million | 5.99 Million | 1.59 Million | 2.06 Million | 244 Thousand |
| Operating Expenses | 19.85 Million | 21.9 Million | 82.18 Million | 21.35 Million | 20.71 Million | 21.26 Million |
| Selling, General and Administrative Expenses | 4.87 Million | 5.83 Million | - | 5.53 Million | 5.76 Million | 5.62 Million |
| Research and Development Expenses | 14.97 Million | 16.07 Million | - | 15.82 Million | 14.95 Million | 15.64 Million |
| Other Expenses | 3.56 Million | 4.67 Million | - | - | - | - |
| Cost and Expenses | 20.3 Million | 22.36 Million | 84.07 Million | 21.85 Million | 20.71 Million | 21.26 Million |
| Operating Income | -19.03 Million | -17.09 Million | -76.19 Million | -19.76 Million | -18.18 Million | -19.83 Million |
| Interest Expense | - | - | - | 1.43 Million | - | - |
| Income Tax Expense | - | 414.72 Thousand | 1.71 Million | 1.89 Million | -462 Thousand | 335.91 Thousand |
| Earnings before Tax | -21.19 Million | -10.81 Million | -69.19 Million | -17.9 Million | -16.25 Million | -18.05 Million |
| Net Income | -21.19 Million | -10.81 Million | -69.19 Million | -17.9 Million | -16.25 Million | -18.05 Million |
| Earnings Per Share Basic | -0.56 | -0.28 | - | -0.47 | -0.43 | -0.48 |
| Earnings Per Share Diluted | -0.56 | -0.28 | - | -0.47 | -0.43 | -0.48 |
| Weighted Average Shares Outstanding | 38.12 Million | 38.06 Million | 37.81 Million | 37.94 Million | 37.86 Million | 37.75 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.12 Million | 38.06 Million | 37.81 Million | 37.94 Million | 37.86 Million | 37.75 Million |
| Gross Margin | 0.64 | 0.91 | 0.76 | 0.76 | 0.82 | 0.17 |
| EBIT Margin | -14.57 | -3.15 | - | -9.22 | -7.19 | -13.52 |
| Profit Margin | -16.62 | -2.05 | -8.79 | -8.57 | -6.43 | -12.60 |
| EBITDA | -18.57 Million | -16.63 Million | - | -19.26 Million | -18.18 Million | -19.37 Million |
| Earnings Before Tax Margin | -14.93 | -3.24 | -9.67 | -9.46 | -7.19 | -13.84 |
XELA
TRDA
0LPE
LASE
0220
EME